Robbins Arroyo LLP: India Globalization Capital, Inc. (IGC) Sued for Misleading Investors
IGC Pharma, Inc. (IGC)
NASDAQ:AMEX Investor Relations:
igcinc.us/investor-center/overview
Company Research
Source: Business Wire
SAN DIEGO & BETHESDA, Md.--(BUSINESS WIRE)-- Shareholder rights law firm Robbins Arroyo LLP announces that a purchaser of India Globalization Capital, Inc. (AMEX: IGC) has filed a derivative complaint against the company's officers and directors for breaches of fiduciary duty from October 25, 2017 through the present. India Globalization develops and commercializes cannabis-based therapies. View this information on the law firm's Shareholder Rights Blog:https://www.robbinsarroyo.com/india-globalization-capital-jun-19/ India Globalization Accused of Inflating Stock Price According to the complaint, since 2017, India Globalization had touted its business prospects and competitive advantage in the medical cannabis industry. However, it had just taken advantage of the cryptocurrency and cannabis-stock craze to send its stock soaring up to $13 per share in October 2018. Executives promoted the usag
Show less
Read more
Impact Snapshot
Event Time:
IGC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IGC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IGC alerts
High impacting IGC Pharma, Inc. news events
Weekly update
A roundup of the hottest topics
IGC
News
- IGC Pharma Announces Participation in BioPartnering at JPM Alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025Accesswire
- Short Sellers' Secret Talks and Alliances Emerge in Court Battle [Yahoo! Finance]Yahoo! Finance
- IGC Pharma Advances IGC-AD1 as a Potential Alzheimer's Therapy Addressing Cognitive Impairment and Underlying Disease PathologyAccesswire
- IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's TreatmentBusiness Wire
- IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s PipelineAccesswire
IGC
Analyst Actions
- 12/5/24 - Ascendiant Capital
IGC
Sec Filings
- 11/12/24 - Form 10-Q
- 9/27/24 - Form 8-K
- 9/27/24 - Form 4
- IGC's page on the SEC website